Table 2.
Participant characteristics of both primary and validation cohorts, stratified by cases and controls
| Participant characteristics | Cases | Controls |
|---|---|---|
| Primary cohort: Lancashire Teaching Hospitals NHS Foundation Trust (n = 59 368) | ||
| Age (years), median [IQR] | 73.7 [60.3-82.6] | 52.8 [36.3-68.7] |
| Female sex, n (%) | 472 (45.6) | 38 000 (66.3) |
| Serum 25(OH)D (nmol/L), mean (SD) | 35.0 [21.0-57.0] | 50.0 [34.2-66.9] |
| Validation cohort: Tameside and Glossop Integrated Care NHS Foundation Trust (n = 21 234) | ||
| Age (years), median [IQR] | 72.5 [60.1-81.5] | 54.5 [39.3-69.7] |
| Female sex, n (%) | 345 (44.7) | 14 182 (69.3) |
| Serum 25(OH)D (nmol/L), mean (SD) | 33.0 [19.4-54.1] | 47.1 [31.8-64.7] |
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; IQR, interquartile range.